mercaptopurine
Showing 26 - 50 of 112
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)
Recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Blinatumomab
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2021
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase Erwinia chrysanthemi
- +15 more
-
Birmingham, Alabama
- +219 more
Aug 24, 2022
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Australia,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Phoenix, Arizona
- +27 more
Apr 2, 2021
Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia
Terminated
- Acute Lymphoblastic Leukemia in Remission
- +2 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Mar 18, 2021
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Calaspargase Pegol-mknl
- +14 more
-
Birmingham, Alabama
- +26 more
Apr 2, 2021
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide
Active, not recruiting
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Azacitidine
- +17 more
-
Birmingham, Alabama
- +173 more
Nov 16, 2021
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)
Suspended
- Down Syndrome
- Recurrent B Acute Lymphoblastic Leukemia
- 3-Dimensional Conformal Radiation Therapy
- +13 more
-
Birmingham, Alabama
- +202 more
Jan 17, 2023
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States
Completed
- Acute Lymphoblastic Leukemia
- Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Alemtuzumab
- +20 more
-
Palo Alto, California
- +100 more
Aug 3, 2022
Acute Leukemia of Ambiguous Lineage Trial in Tianjin (vincristine, daunorubicin, cyclophosphamide)
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- vincristine
- +8 more
-
Tianjin, Tianjin, ChinaHBDH
Jun 17, 2020
Acute Lymphobkastic Leukemia Trial in Barcelona (Vincristine, Daunorubicin, Prednisone)
Completed
- Acute Lymphobkastic Leukemia
- Vincristine
- +10 more
-
Barcelona, SpainHospital Germans Trias i Pujol
Mar 3, 2020
Langerhans Cell Histiocytosis Trial in United States (drug, procedure, biological)
Recruiting
- Langerhans Cell Histiocytosis
- Prednisone
- +8 more
-
Birmingham, Alabama
- +35 more
Feb 17, 2022
Acute Lymphoblastic Leukemia Trial (Mercaptopurine)
Unknown status
- Acute Lymphoblastic Leukemia
- Mercaptopurine
- (no location specified)
Apr 19, 2019
Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood
Active, not recruiting
- Adult T Acute Lymphoblastic Leukemia
- +7 more
- Bortezomib
- +18 more
-
Birmingham, Alabama
- +211 more
Jan 26, 2022
Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia Trial in Worldwide
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase
- +17 more
-
Birmingham, Alabama
- +169 more
Aug 17, 2022
Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +5 more
-
Innsbruck, Austria
- +109 more
Oct 10, 2022
Young Acute Lymphoblastic Leukemia in Remission
Completed
- Childhood Acute Lymphoblastic Leukemia in Remission
- Compliance Monitoring
- +5 more
-
Birmingham, Alabama
- +134 more
Jul 1, 2020
Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide (3-Dimensional Conformal Radiation
Completed
- Acute Lymphoblastic Leukemia
- Childhood B Acute Lymphoblastic Leukemia
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Birmingham, Alabama
- +235 more
Jun 11, 2021
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +21 more
-
Birmingham, Alabama
- +219 more
Sep 15, 2022
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Birmingham, Alabama
- +233 more
Apr 2, 2021
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Allogeneic Hematopoietic Stem Cell Transplantation
- +15 more
-
Birmingham, Alabama
- +550 more
Jan 28, 2023
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Daunorubicin, Vincristine, PEG-asparaginase)
Completed
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Daunorubicin
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 21, 2019